Cyber Monday saleUp to 70% OFF

Akebia Therapeutics, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

AKBA chart

Key stats

Market capitalization
186.543MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.3287USD
Net income
−94.226MUSD
Revenue
292.484MUSD
Shares float
167.053M
Beta
1.01

About Akebia Therapeutics, Inc.

Sector
Health Technology
CEO
John P. Butler
Headquarters
Cambridge
Website
akebia.com
Employees (FY)
205
Founded
2007
ISIN
US00972D1054
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Ideas

$AKBA Therapeutics $1.25 is already programmed - Long/CallFully expect a good earnings report. Positive news from the company. Nothing but good news as far as this company is concerned. Earnings posting this week, and will not disappoint. We could see a nice jump up here.
Long
by GoldenCrowley
1
Possible trend change on AKBAOn the weekly chart: We're hitting a major horizontal support line on the weekly chart. On the daily chart: we have a nice doji candle. Could be a start for an uptrend if we break over 2:57 Weekly price action tends to have more weight on the price. Could be one of the double your money moves. I'm n
Long
by ahmedmedan1234
1
AKBA LongWeekly Demand Zone Entry 2.47 Stop 1.9 Target 5 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost.
Long
by PlanTradePlanMM

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers